Cargando…

Prevention of progression in Parkinson’s disease

Environmental influences affecting genetically susceptible individuals seem to contribute significantly to the development of Parkinson’s disease (PD). Xenobiotic exposure including transitional metal deposition into vulnerable CNS regions appears to interact with PD genes. Such exposure together wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aaseth, Jan, Dusek, Petr, Roos, Per M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133181/ https://www.ncbi.nlm.nih.gov/pubmed/30030679 http://dx.doi.org/10.1007/s10534-018-0131-5

Ejemplares similares

Treatment strategies in Alzheimer’s disease: a review with focus on selenium supplementation
por: Aaseth, Jan, et al.
Publicado: (2016)

Cerebral Iron Deposition in Neurodegeneration
por: Dusek, Petr, et al.
Publicado: (2022)

Short-term effect of dopaminergic medication on speech in early-stage Parkinson’s disease
por: Tykalova, Tereza, et al.
Publicado: (2022)

Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
por: Rusz, Jan, et al.
Publicado: (2021)

Automated video-based assessment of facial bradykinesia in de-novo Parkinson’s disease
por: Novotny, Michal, et al.
Publicado: (2022)

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease
por: Aaseth, Jan, et al.
Publicado: (2021)

Speech and gait abnormalities in motor subtypes of de‐novo Parkinson's disease
por: Rusz, Jan, et al.
Publicado: (2023)

Articulatory undershoot of vowels in isolated REM sleep behavior disorder and early Parkinson’s disease
por: Skrabal, Dominik, et al.
Publicado: (2022)

Predicting Falls in Parkinson Disease: What Is the Value of Instrumented Testing in OFF Medication State?
por: Hoskovcová, Martina, et al.
Publicado: (2015)

Abnormal Activity in the Precuneus during Time Perception in Parkinson's Disease: An fMRI Study
por: Dušek, Petr, et al.
Publicado: (2012)

Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
por: Chen, Ping, et al.
Publicado: (2023)

Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson’s disease
por: Hasíková, Lenka, et al.
Publicado: (2023)

Toxic and Essential Metals in Human Health and Disease 2021
por: Aaseth, Jan O.
Publicado: (2022)

Topography of emotional valence and arousal within the motor part of the subthalamic nucleus in Parkinson’s disease
por: Serranová, Tereza, et al.
Publicado: (2019)

Targeting the Progression of Parkinson’s Disease
por: George, J.L, et al.
Publicado: (2009)

Dietary Supplementation with Selenium and Coenzyme Q(10) Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population
por: Alehagen, Urban, et al.
Publicado: (2021)

The Subthalamic Microlesion Story in Parkinson's Disease: Electrode Insertion-Related Motor Improvement with Relative Cortico-Subcortical Hypoactivation in fMRI
por: Jech, Robert, et al.
Publicado: (2012)

The Parkinson's Disease Progression Neuroimaging Initiative
por: Zhu, Shiyi, et al.
Publicado: (2021)

Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
por: Brumm, Michael C., et al.
Publicado: (2023)

Early Nutritional Interventions with Zinc, Selenium and Vitamin D for Raising Anti-Viral Resistance Against Progressive COVID-19
por: Alexander, Jan, et al.
Publicado: (2020)

CSF, Blood, and MRI Biomarkers in Skogholt’s Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred
por: Aspli, Klaus Thanke, et al.
Publicado: (2023)

The Role of Tryptophan Dysmetabolism and Quinolinic Acid in Depressive and Neurodegenerative Diseases
por: Hestad, Knut, et al.
Publicado: (2022)

APOE Polymorphism and Endocrine Functions in Subjects with Morbid Obesity Undergoing Bariatric Surgery
por: Farup, Per G., et al.
Publicado: (2022)

Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
por: Aaseth, Jan O., et al.
Publicado: (2022)

Preventing Parkinson’s Disease: An Environmental Agenda
por: De Miranda, Briana R., et al.
Publicado: (2022)

Progression of Cognitive Decline in Parkinson’s Disease
por: Roheger, Mandy, et al.
Publicado: (2018)

Molecular mechanisms of in vivo metal chelation: implications for clinical treatment of metal intoxications.
por: Andersen, Ole, et al.
Publicado: (2002)

Selenium and Coenzyme Q(10) Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality—Sub-Study of a Randomized Clinical Trial
por: Opstad, Trine Baur, et al.
Publicado: (2022)

Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
por: Talai, Aron S., et al.
Publicado: (2018)

Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism
por: Degerman, Sofie, et al.
Publicado: (2014)

Recent Progress of Imaging Agents for Parkinson's Disease
por: Wu, Xiaoai, et al.
Publicado: (2014)

Accuracy Improvement for Predicting Parkinson’s Disease Progression
por: Nilashi, Mehrbakhsh, et al.
Publicado: (2016)

Reproductive Lifespan and Motor Progression of Parkinson’s Disease
por: Ou, Ruwei, et al.
Publicado: (2022)

Progress toward an integrated understanding of Parkinson’s disease
por: Rousseaux, Maxime W.C., et al.
Publicado: (2017)

Progressive decline of glucocerebrosidase in aging and Parkinson's disease
por: Rocha, Emily M, et al.
Publicado: (2015)

Molecules That Cause or Prevent Parkinson's Disease
por: Cookson, Mark R
Publicado: (2004)

Parkinson's disease as a preventable pandemic
por: Barker, Roger A
Publicado: (2020)

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
por: Bloem, B. R., et al.
Publicado: (2019)

Reply to Paredes et al. Comment on “Aaseth et al. Circulating Lipoproteins in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy. Nutrients 2022, 14, 2381”
por: Aaseth, Jan O., et al.
Publicado: (2022)

Postoperative Osteoporosis in Subjects with Morbid Obesity Undergoing Bariatric Surgery with Gastric Bypass or Sleeve Gastrectomy
por: Aaseth, Jan O., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_11u70k441k015t6am3m5skcumb